Pcas SA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pcas SA with three other
pharmaceutical manufacturers in Europe:
Vectura Group PLC
of the United Kingdom
sales of £168.25 million [US$224.03 million]
of which 100%
was Pharmaceutical Prod),
Laboratorio Reig Jofre SA
(161.13 million Euro [US$191.14 million]
of which 87%
was Sale of Pharmaceutical Products), and
based in Germany
(164.51 million Euro [US$195.14 million]
of which 84%
was EVT Execute).
During the year ended December of 2016, sales at
Pcas SA were 191.99 million Euro (US$227.75 million).
increase of 7.2%
versus 2015, when the company's sales were 179.09 million Euro.
This was the third consecutive year of growth at Pcas SA.
Sales of Pharmaceutical Synthesis saw an increase
7.6% in 2016, from
120.77 million Euro to 129.97 million Euro.